These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16105909)

  • 1. Potential failure of contraceptive efficacy in a patient taking methotrexate.
    Williamson L; Yein K
    Rheumatology (Oxford); 2005 Nov; 44(11):1461-2. PubMed ID: 16105909
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.
    Tian H; Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation dependent apoptosis of peripheral blood mononuclear cells from patients with rheumatoid arthritis treated with methotrexate.
    Swierkot J; Miedzybrodzki R; Szymaniec S; Szechinski J
    Ann Rheum Dis; 2004 May; 63(5):599-600. PubMed ID: 15082496
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis.
    Kremer JM
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():26-9. PubMed ID: 8535645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the effects of methotrexate.
    Cronstein BN; Merrill JT
    Bull Rheum Dis; 1996 Aug; 45(5):6-8. PubMed ID: 8768499
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
    Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE
    J Clin Pharmacol; 2007 Sep; 47(9):1119-28. PubMed ID: 17766699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.
    van der Heijden JW; Dijkmans BA; Scheper RJ; Jansen G
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):26-34. PubMed ID: 17203006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methotrexate therapy for rheumatism and collagen diseases].
    Osone Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):330-6. PubMed ID: 16646163
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease-modifying antirheumatic drugs.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al.
    Morgan SL; Baggott JE; Alarcón GS
    Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate pharmacogenomics.
    Kremer JM
    Ann Rheum Dis; 2006 Sep; 65(9):1121-3. PubMed ID: 16905578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis.
    Castaneda O; Nair MG
    J Rheumatol; 2006 May; 33(5):862-4. PubMed ID: 16652417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Going with the flow: methotrexate, adenosine, and blood flow.
    Cronstein BN
    Ann Rheum Dis; 2006 Apr; 65(4):421-2. PubMed ID: 16531550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Images in clinical medicine. Bone changes in rheumatoid arthritis.
    Ikari K; Momohara S
    N Engl J Med; 2005 Oct; 353(15):e13. PubMed ID: 16221769
    [No Abstract]   [Full Text] [Related]  

  • 18. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
    Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving pregnancy counseling for women with rheumatoid arthritis taking methotrexate.
    Neeman N; Aronson MD; Schulze JE; Shmerling RH
    Am J Med; 2009 Nov; 122(11):998-1000. PubMed ID: 19854323
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods to enhance the safety of methotrexate prescribing.
    Goldsmith P; Roach A
    J Clin Pharm Ther; 2007 Aug; 32(4):327-31. PubMed ID: 17635334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.